Receptor-mediated transcytosis for brain delivery of therapeutics: receptor classes and criteria
The delivery of therapeutics into the brain is highly limited by the blood-brain barrier (BBB). Although this is essential to protect the brain from potentially harmful material found in the blood, it poses a great challenge for the treatment of diseases affecting the central nervous system (CNS). S...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-03-01
|
| Series: | Frontiers in Drug Delivery |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fddev.2024.1360302/full |